Please login to the form below

Not currently logged in
Email:
Password:

Shire adds Sara Mathew to board of directors

Comes as firm aims to become global biotechnology leader
Shire Sara Mathew

Shire has appointed Sara Mathew to its board of directors as a non-executive director.

Mathew who has previously served as chairman, president and CEO of Dun & Bradstreet will also be a member of the audit, compliance and risk committee of the Shire board.

During her 12-year tenure at Dun & Bradstreet she helped transform the company from being a data provider to an innovative digital enterprise that leverages big data, insights and analytics.

In 2013, Mathew was named the top value creator in the S&P 500 by Chief Executive magazine.

Susan Kilsby, chairman at Shire, said: “Sara is a highly-skilled global leader who has demonstrated success in driving strategy and transformation to deliver value for stakeholders.

“Sara also understands first-hand the power of disruptive technologies to substantially influence business in the future, an emerging dynamic in healthcare.

“I am confident that Sara's unique combination of skills and experience will further enrich the Shire Board of Directors as we advance towards becoming a global biotechnology leader.”

8th September 2015

From: Research, Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...